GHK-Cu Research Guide — What Studies Show (2026)
⚠️ Research Use Only. This post is educational and does not constitute medical advice. All peptides discussed are sold for research purposes only. See our full disclaimer.
Overview
GHK-Cu is a naturally occurring copper-binding tripeptide studied for skin remodeling, wound healing, and hair follicle research.
What is GHK-Cu?
GHK-Cu, short for glycyl-L-histidyl-L-lysine-copper, is a tripeptide-copper complex that occurs naturally in human plasma, saliva, and urine. Levels decline sharply with age — plasma concentrations in a 60-year-old are roughly a third of those in a 20-year-old, which has driven much of the interest in GHK-Cu as an anti-aging research compound.
The peptide's most striking property is its effect on gene expression. A 2010 paper by Pickart and colleagues showed GHK-Cu modulates the expression of over 4,000 human genes, with broad effects on tissue remodeling, antioxidant response, and inflammation. In skin research, GHK-Cu has been studied for collagen synthesis, glycosaminoglycan production, and reduction of fine lines. In wound healing models, it accelerates closure and reduces scarring.
Hair research has explored GHK-Cu's effect on dermal papilla cells in vitro, with some studies showing increased follicle size and prolonged anagen phase. This is preliminary and not equivalent to clinical hair loss treatment.
Research routes include subcutaneous injection (typically 1-3 mg, several times per week), topical formulations (commonly 0.05-0.2%), and occasionally intramuscular. Reconstituted GHK-Cu appears bright blue from the copper chelate — a reasonable visual purity check.
Top Research Uses
- Skin repair
- Wound healing
- Hair growth research
- Collagen production
- Anti-aging skin
Mechanism of Action
Copper carrier peptide that signals tissue remodeling, modulates over 4,000 human genes, and stimulates collagen and elastin synthesis
Research Parameters
| Half-Life | Topical: hours; subq: short, hours |
| Typical Research Dose | Research protocols commonly cite 1-3 mg subq or topical 0.05-0.2% formulations |
| Administration Route | Subcutaneous, topical, intramuscular |
| Reported Side Effects | Mild injection site reactions; topical formulations occasionally cause transient redness |
Dosing ranges cited from published research literature. These are not recommendations for human use. GHK-Cu is a research compound — not for human consumption.
Research Strength: Moderate
GHK-Cu has a moderate research base, with a reasonable number of studies examining its proposed mechanisms. More research is ongoing.
Vendor & Sourcing Notes
Widely available as research-grade lyophilized powder; copper-bound versions appear blue when reconstituted
Always request third-party HPLC purity reports and mass spectrometry verification when sourcing research peptides. Quality varies significantly between suppliers.
Research Use Only — Compliance Notice
The information on this page is intended for educational and informational purposes only. GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper) is a research compound sold for laboratory research purposes only. It has not been approved by the FDA for human use. Nothing on this page constitutes medical advice or is intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Consult a qualified healthcare professional before considering any peptide-related protocols.